LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Suchergebnis

Treffer 1 - 1 von insgesamt 1

Suchoptionen

Artikel ; Online: Iloprost as an acute kidney injury-triggering agent in severely atherosclerotic patients.

Uyar, Mehtap Erkmen / Yucel, Piril / Ilin, Sena / Bal, Zeynep / Yildirim, Saliha / Uyar, Ahmet Senol / Akay, Tankut / Tutal, Emre / Sezer, Siren

Cardiovascular journal of Africa

2016  Band 27, Heft 3, Seite(n) 128–133

Abstract: Background: Iloprost, a stable prostacyclin analog, is used as a rescue therapy for severe peripheral arterial disease (PAD). It has systemic vasodilatory and anti-aggregant effects, with severe vasodilatation potentially causing organ ischaemia when ... ...

Abstract Background: Iloprost, a stable prostacyclin analog, is used as a rescue therapy for severe peripheral arterial disease (PAD). It has systemic vasodilatory and anti-aggregant effects, with severe vasodilatation potentially causing organ ischaemia when severe atherosclerosis is the underlying cause. In this study, we retrospectively analysed renal outcomes after iloprost infusion therapy in 86 patients.
Methods: Eighty-six patients with PAD who received iloprost infusion therapy were retrospectively analysed. Clinical and biochemical parameters were recorded before (initial, Cr1), during (third day, Cr2), and after (14th day following the termination of infusion therapy, Cr3) treatment. Acute kidney injury (AKI) was defined according to KDIGO guidelines as a ≥ 0.3 mg/dl (26.52 µmol/l) increase in creatinine levels from baseline within 48 hours.
Results: Cr2 (1.46 ± 0.1 mg/dl) (129.06 ± 8.84 µmol/l) and Cr3 (1.53 ± 0.12 mg/dl) (135.25 ± 10.61 µmol/l) creatinine levels were significantly higher compared to the initial value (1.15 ± 0.6 mg/dl) (101.66 ± 53.04 µmol/l). AKI was observed in 36 patients (41.86%) on the third day of iloprost infusion. Logistic regression analysis revealed smoking and not using acetylsalicylic acid as primary predictors (p = 0.02 and p = 0.008, respectively) of AKI during iloprost treatment. On the third infusion day, patients' urinary output significantly increased (1813.30 ± 1123.46 vs 1545.17 ± 873.00 cm
Conclusion: While iloprost treatment is effective in patients with PAD who are not suitable for surgery, severe systemic vasodilatation can cause renal ischaemia, resulting in nonoliguric AKI. Smoking, no acetylsalicylic acid use, and lower diastolic blood pressure are the clinical risk factors for AKI during iloprost treatment.
Mesh-Begriff(e) Acute Kidney Injury/blood ; Acute Kidney Injury/chemically induced ; Acute Kidney Injury/diagnosis ; Acute Kidney Injury/mortality ; Aged ; Aged, 80 and over ; Arterial Pressure ; Aspirin/therapeutic use ; Atherosclerosis/diagnostic imaging ; Atherosclerosis/drug therapy ; Atherosclerosis/mortality ; Atherosclerosis/physiopathology ; Biomarkers/blood ; Chi-Square Distribution ; Creatinine/blood ; Female ; Humans ; Iloprost/administration & dosage ; Iloprost/adverse effects ; Infusions, Intravenous ; Kaplan-Meier Estimate ; Logistic Models ; Male ; Middle Aged ; Platelet Aggregation Inhibitors/administration & dosage ; Platelet Aggregation Inhibitors/adverse effects ; Protective Factors ; Retrospective Studies ; Risk Assessment ; Risk Factors ; Severity of Illness Index ; Smoking/adverse effects ; Time Factors ; Treatment Outcome ; Up-Regulation ; Vasodilator Agents/administration & dosage ; Vasodilator Agents/adverse effects
Chemische Substanzen Biomarkers ; Platelet Aggregation Inhibitors ; Vasodilator Agents ; Creatinine (AYI8EX34EU) ; Iloprost (JED5K35YGL) ; Aspirin (R16CO5Y76E)
Sprache Englisch
Erscheinungsdatum 2016-05
Erscheinungsland South Africa
Dokumenttyp Journal Article
ZDB-ID 2383233-2
ISSN 1680-0745 ; 1996-3467 ; 1015-9657 ; 1995-1892
ISSN (online) 1680-0745 ; 1996-3467
ISSN 1015-9657 ; 1995-1892
DOI 10.5830/CVJA-2015-051
Signatur
Zs.A 4813: Hefte anzeigen Standort:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)
Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

Zusatzmaterialien

Kategorien

Zum Seitenanfang